Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064507
Filing Date
2025-05-06
Accepted
2025-05-06 16:21:10
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-20250331.htm   iXBRL 10-Q 1674894
2 EX-31.1 crbp-ex31_1.htm EX-31.1 18078
3 EX-31.2 crbp-ex31_2.htm EX-31.2 18204
4 EX-32.1 crbp-ex32_1.htm EX-32.1 10640
5 EX-32.2 crbp-ex32_2.htm EX-32.2 10570
  Complete submission text file 0000950170-25-064507.txt   8406661

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20250331.xsd EX-101.SCH 1364767
75 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20250331_htm.xml XML 1476860
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 25917583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)